Jason V. Rowley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jason V. Rowley has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Paul David Thornton
Leeds Institute of Textiles and Colour (LITAC) School of Design University of Leeds Leeds United Kingdom
7 shared publications - Huayang Yu
School of Chemistry, University of Leeds, Leeds, UK
4 shared publications - David C. Green
School of Chemistry, University of Leeds, Leeds, UK
3 shared publications Huayang Yu
School of Chemistry, University of Leeds, Leeds LS2 9JT, U.K.
3 shared publicationsDavid C. Green
University of Leeds, Chemistry, Woodhouse Lane, UNITED KINGDOM
2 shared publicationsNicola Ingram
University of Leeds, Institute of Biomedical and Clinical Sciences, Becket Street, UNITED KINGDOM
2 shared publications
Latest Publications
- Open Access
- 30 November 2021
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 13 (1) , 100-108
Triggered and monitored drug release from bifunctional hybrid nanocomposites
Polymer-coated carbon dot-containing calcium carbonate nanoparticles are reported as unique nanocomposites capable of encapsulating a chemotherapeutic drug and displaying afterglow behaviour.
- 30 November 2021
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 13 (1) , 100-108
Open AccessTriggered and monitored drug release from bifunctional hybrid nanocomposites
Polymer-coated carbon dot-containing calcium carbonate nanoparticles are reported as unique nanocomposites capable of encapsulating a chemotherapeutic drug and displaying afterglow behaviour.
- Open Access
- 14 July 2020
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 1 (5) , 1293-1300
Fucose-modified thermoresponsive poly(2-hydroxypropyl methacrylate) nanoparticles for controlled doxorubicin release from an injectable depot
The modification of poly(2-hydroxypropyl methacrylate) with a single fucose group per polymer chain enabled macromolecular self-assembly, and the formation of thermoresponsive nanoparticles that could selectively release doxorubicin.
- 14 July 2020
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 1 (5) , 1293-1300
Open AccessFucose-modified thermoresponsive poly(2-hydroxypropyl methacrylate) nanoparticles for controlled doxorubicin release from an injectable depot
The modification of poly(2-hydroxypropyl methacrylate) with a single fucose group per polymer chain enabled macromolecular self-assembly, and the formation of thermoresponsive nanoparticles that could selectively release doxorubicin.
- 29 May 2020
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 2 (7) , 2927-2933
Antimicrobial Dye-Conjugated Polyglobalide-Based Organogels
- 29 May 2020
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 2 (7) , 2927-2933
Antimicrobial Dye-Conjugated Polyglobalide-Based Organogels
- Open Access
- 30 April 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (47) , 6360-6363
Covalent polyester colouration by in situ chromophore creation
The covalent, in situ , colouration of a condensation polymer is disclosed as a template for simple and effective polyester colouration.
- 30 April 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (47) , 6360-6363
Open AccessCovalent polyester colouration by in situ chromophore creation
The covalent, in situ , colouration of a condensation polymer is disclosed as a template for simple and effective polyester colouration.
- 24 April 2020
- Published by Wiley in Chemistry – A European Journal
- Vol. 26 (59) , 13352-13358
Meticulous Doxorubicin Release from pH‐Responsive Nanoparticles Entrapped within an Injectable Thermoresponsive Depot
The dual stimuli‐controlled release of doxorubicin from gel‐embedded nanoparticles is reported. Non‐cytotoxic polymer nanoparticles are formed from poly(ethylene glycol)‐b‐poly(benzyl glutamate) that, uniquely, contain a central ester link. This connection renders the nanoparticles pH‐responsive, enabling extensive doxorubicin release in acidic solutions (pH 6.5), but not in solutions of physiological pH (pH 7.4). Doxorubicin‐loaded nanoparticles were found to be stable for at least 31 days and lethal against the three breast cancer cell lines tested. Furthermore, doxorubicin‐loaded nanoparticles could be incorporated within a thermoresponsive poly(2‐hydroxypropyl methacrylate) gel depot, which forms immediately upon injection of poly(2‐hydroxypropyl methacrylate) in dimethyl sulfoxide solution into aqueous solution. The combination of the poly(2‐hydroxypropyl methacrylate) gel and poly(ethylene glycol)‐b‐poly(benzyl glutamate) nanoparticles yields an injectable doxorubicin delivery system that facilities near‐complete drug release when maintained at elevated temperatures (37 °C) in acidic solution (pH 6.5). In contrast, negligible payload release occurs when the material is stored at room temperature in non‐acidic solution (pH 7.4). The system has great potential as a vehicle for the prolonged, site‐specific release of chemotherapeutics.
- 24 April 2020
- Published by Wiley in Chemistry – A European Journal
- Vol. 26 (59) , 13352-13358
Meticulous Doxorubicin Release from pH‐Responsive Nanoparticles Entrapped within an Injectable Thermoresponsive Depot
The dual stimuli‐controlled release of doxorubicin from gel‐embedded nanoparticles is reported. Non‐cytotoxic polymer nanoparticles are formed from poly(ethylene glycol)‐b‐poly(benzyl glutamate) that, uniquely, contain a central ester link. This connection renders the nanoparticles pH‐responsive, enabling extensive doxorubicin release in acidic solutions (pH 6.5), but not in solutions of physiological pH (pH 7.4). Doxorubicin‐loaded nanoparticles were found to be stable for at least 31 days and lethal against the three breast cancer cell lines tested. Furthermore, doxorubicin‐loaded nanoparticles could be incorporated within a thermoresponsive poly(2‐hydroxypropyl methacrylate) gel depot, which forms immediately upon injection of poly(2‐hydroxypropyl methacrylate) in dimethyl sulfoxide solution into aqueous solution. The combination of the poly(2‐hydroxypropyl methacrylate) gel and poly(ethylene glycol)‐b‐poly(benzyl glutamate) nanoparticles yields an injectable doxorubicin delivery system that facilities near‐complete drug release when maintained at elevated temperatures (37 °C) in acidic solution (pH 6.5). In contrast, negligible payload release occurs when the material is stored at room temperature in non‐acidic solution (pH 7.4). The system has great potential as a vehicle for the prolonged, site‐specific release of chemotherapeutics.
- Open Access
- 29 November 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 7 (48) , 7795
Correction: Thermoresponsive polysarcosine-based nanoparticles
Correction for ‘Thermoresponsive polysarcosine-based nanoparticles’ by Huayang Yu et al., J. Mater. Chem. B, 2019, 7, 4217–4223.
- 29 November 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 7 (48) , 7795
Open AccessCorrection: Thermoresponsive polysarcosine-based nanoparticles
Correction for ‘Thermoresponsive polysarcosine-based nanoparticles’ by Huayang Yu et al., J. Mater. Chem. B, 2019, 7, 4217–4223.
- Open Access
- 5 June 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 7 (26) , 4217-4223
Thermoresponsive polysarcosine-based nanoparticles
Polysarcosine holds great promise as an alternative to poly(ethylene glycol) for use within both biomedical and non-biomedical applications owing to its hydrophilicity and non-cytoxicity, amongst other features. The grafting of a limited quantity of (N-(2-hydroxypropyl)methacrylamide) to polysarcosine, for instance 3.5% of the total copolymer in terms of the number of repeat units, has a profound effect on the properties of the copolymer formed; polymer self-assembly to yield thermoreponsive nanoparticles can now be realised. Such nanoparticles are non-cytotoxic against a range of human breast cancer cell lines, able to withhold the therapeutic compound doxorubicin, and allow pronounced doxorubicin release in response to subtle thermal stimulation. This research informs of how the straightforward modification of polysarcosine with a nominal molar amount of poly(N-(2-hydroxypropyl)methacrylamide) can yield stimuli-responsive polymers that are suitable for use within controlled release applications.
- 5 June 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 7 (26) , 4217-4223
Open AccessThermoresponsive polysarcosine-based nanoparticles
Polysarcosine holds great promise as an alternative to poly(ethylene glycol) for use within both biomedical and non-biomedical applications owing to its hydrophilicity and non-cytoxicity, amongst other features. The grafting of a limited quantity of (N-(2-hydroxypropyl)methacrylamide) to polysarcosine, for instance 3.5% of the total copolymer in terms of the number of repeat units, has a profound effect on the properties of the copolymer formed; polymer self-assembly to yield thermoreponsive nanoparticles can now be realised. Such nanoparticles are non-cytotoxic against a range of human breast cancer cell lines, able to withhold the therapeutic compound doxorubicin, and allow pronounced doxorubicin release in response to subtle thermal stimulation. This research informs of how the straightforward modification of polysarcosine with a nominal molar amount of poly(N-(2-hydroxypropyl)methacrylamide) can yield stimuli-responsive polymers that are suitable for use within controlled release applications.